Tekla Healthcare Net Worth
Tekla Healthcare Net Worth Breakdown | HQH |
Tekla Healthcare Net Worth Analysis
Tekla Healthcare's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Tekla Healthcare's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Tekla Healthcare's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Tekla Healthcare's net worth analysis. One common approach is to calculate Tekla Healthcare's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Tekla Healthcare's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Tekla Healthcare's net worth. This approach calculates the present value of Tekla Healthcare's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Tekla Healthcare's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Tekla Healthcare's net worth. This involves comparing Tekla Healthcare's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Tekla Healthcare's net worth relative to its peers.
Enterprise Value |
|
To determine if Tekla Healthcare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Tekla Healthcare's net worth research are outlined below:
| Tekla Healthcare Inv generated a negative expected return over the last 90 days | |
| Tekla Healthcare Inv has high likelihood to experience some financial distress in the next 2 years | |
| Tekla Healthcare Investors has about 62 in cash with (65.41 M) of positive cash flow from operations. | |
| On 30th of September 2024 Tekla Healthcare paid $ 0.59 per share dividend to its current shareholders | |
| Latest headline from MacroaxisInsider: Acquisition by Dimartino Rose of 1000 shares of Tekla Healthcare at 18.88 subject to Rule 16b-3 |
Follow Tekla Healthcare's market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 873.28 M.Market Cap |
|
Project Tekla Healthcare's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.07 | 0.08 | |
| Return On Assets | 0.07 | 0.08 | |
| Return On Equity | 0.07 | 0.08 |
When accessing Tekla Healthcare's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Tekla Healthcare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Tekla Healthcare's profitability and make more informed investment decisions.
Evaluate Tekla Healthcare's management efficiency
As of now, Tekla Healthcare's Return On Tangible Assets are decreasing as compared to previous years. The Tekla Healthcare's current Return On Assets is estimated to increase to 0.08, while Return On Capital Employed is forecasted to increase to (0). As of now, Tekla Healthcare's Asset Turnover is increasing as compared to previous years. Tekla Healthcare's management efficiency ratios could be used to measure how well Tekla Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 21.66 | 22.52 | |
| Tangible Book Value Per Share | 21.66 | 22.52 | |
| Enterprise Value Over EBITDA | 15.69 | 16.48 | |
| Price Book Value Ratio | 0.74 | 0.58 | |
| Enterprise Value Multiple | 15.69 | 16.48 | |
| Price Fair Value | 0.74 | 0.58 | |
| Enterprise Value | 691.9 M | 518 M |
At Tekla Healthcare Inv, management's focus on innovation and efficiency has led to impressive financial results. We assess these factors to determine the stock's attractiveness to investors.
Enterprise Value Revenue 11.7133 | Revenue 10 M | Quarterly Revenue Growth (0.06) | Revenue Per Share 0.197 | Return On Equity 0.0734 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tekla Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tekla Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Tekla Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Tekla Healthcare Corporate Filings
F3 | 18th of November 2024 An amendment to the original Schedule 13D filing | ViewVerify |
| 3rd of September 2024 Other Reports | ViewVerify | |
| 28th of August 2024 Other Reports | ViewVerify | |
| 15th of August 2024 Other Reports | ViewVerify |
Tekla Healthcare Earnings per Share Projection vs Actual
Tekla Healthcare Corporate Management
| Christopher MBA | Senior Manager | Profile | |
| Dr MS | Portfolio Manager | Profile | |
| Lucinda Stebbins | Independent Trustee | Profile | |
| Jeffrey Bailey | Independent Trustee | Profile | |
| Rakesh Jain | Independent Trustee | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Tekla Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Healthcare. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.145 | Dividend Share 1.66 | Earnings Share 1.31 | Revenue Per Share 0.197 | Quarterly Revenue Growth (0.06) |
The market value of Tekla Healthcare Inv is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tekla Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Healthcare's market value can be influenced by many factors that don't directly affect Tekla Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.